Immunovant Inc (IMVT)
26.54
+0.37
(+1.41%)
USD |
NASDAQ |
Nov 21, 16:00
26.54
0.00 (0.00%)
After-Hours: 20:00
Immunovant Total Liabilities (Quarterly): 66.65M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 66.65M |
| June 30, 2024 | 45.02M |
| March 31, 2024 | 48.61M |
| December 31, 2023 | 32.10M |
| September 30, 2023 | 40.26M |
| June 30, 2023 | 51.36M |
| March 31, 2023 | 43.34M |
| December 31, 2022 | 41.56M |
| September 30, 2022 | 32.40M |
| June 30, 2022 | 22.16M |
| March 31, 2022 | 45.74M |
| December 31, 2021 | 38.03M |
| Date | Value |
|---|---|
| September 30, 2021 | 30.34M |
| June 30, 2021 | 22.50M |
| March 31, 2021 | 21.01M |
| December 31, 2020 | 18.88M |
| September 30, 2020 | 15.49M |
| June 30, 2020 | 22.52M |
| March 31, 2020 | 15.32M |
| December 31, 2019 | 14.76M |
| September 30, 2019 | 4.363M |
| June 30, 2019 | 4.116M |
| March 31, 2019 | 0.3004M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.76M
Minimum
Dec 2019
66.65M
Maximum
Sep 2024
33.40M
Average
32.25M
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 62.68M |
| Electromed Inc | 7.427M |
| Xtant Medical Holdings Inc | 53.16M |
| Myomo Inc | 7.020M |
| Catheter Precision Inc | 13.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 515.71M |
| Shareholders Equity (Quarterly) | 449.05M |